Market Cap

Everest Medicines Ltd Market Capitalization:

HK$6.06 Billion

HKD as of Jan. 1, 2024

US$775.7 Million

business Everest Medicines Ltd Company Profile

Everest Medicines Ltd Main Stock Listing

HKEX: 1952

Market Capitalization History of Everest Medicines Ltd

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Everest Medicines Ltd market cap

Date Market Cap YoY Change
Jan. 1, 2024 HK$6.06 B -17.86%
Jan. 1, 2023 HK$7.37 B -3.86%
Jan. 1, 2022 HK$7.67 B -69.22%
Jan. 1, 2021 HK$24.92 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +298.72%

$10,000 in April 2023 would now be $39,872 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Everest Medicines Ltd Categories

China languages Healthcare languages Biotechnology
China Healthcare China Biotechnology

Stocks & Indices

Everest Medicines Ltd has the following listings and related stock indices.


Stock: HKEX: 1952

Stock: FSX: 6HN

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.